THE CURENTSITUATION OF USING DRUGS TO PREVENT VENOUS THROMBOEMBOLISM IN SURGICAL PATIENTS AT NGHE AN GENERAL FRIENDSHIP HOSPITAL

Nguyễn Văn Tuấn, Trần Thị Anh Thơ

Main Article Content

Abstract

Research objectives: To assess the current situation of using drugs to prevent venous thromboembolism in surgical patients at the Nghe An General Fiendship Hospital. Subjects and research methods: Descriptive cross-sectional study was conducted on 131 surgical patients who were indicated to use drugs to prevent thrombosis in the surgical department of Nghe An General Fiendship Hospital. Results: (1) The rate of prevention of reasonable venous thromboembolism was very high (96.95%); (2) According to VNHA 2016's guidance, the percentage of patients using a suitable anticoagulant is 93.89%; (3) All surgical patients have an appropriate time for taking anticoagulants; (4) There is a high proportion of appropriate timing of using drugs to prevent venous thromboembolism, including orthopedic surgery (82.25%), non-orthopedic surgery (72.22%); (5) The proportion of patients with non-orthopedic surgery who have used anticoagulants in accordance with the recommendation is 71.43%, while the orthopedic surgery patients have time to use anticoagulants which conforms to recommendations is lower (43.55%). Conclusion: The proportion of patients with reasonable prophylaxis against venous thromboembolism was very high (96.95%). The proportion of patients receiving an appropriate anticoagulant is 93.89%. All surgical patients have an appropriate timing of anticoagulant therapy. The right time to use drugs to prevent venous thromboembolism has a high rate

Article Details

References

1. Hội tim mạch học Việt Nam (2016), "Khuyến cáo về chẩn đoán, điều trị và dự phòng thuyên tắc huyết khối tĩnh mạch", tr. 1-64.
2. Bộ Y tế (2018), Dược thư quốc gia Việt Nam, Nhà xuất bản Y học
3. Zhamak Khorgami, MD, Roza Mofid, MD (2012), Factors Associated With Inappropriate Chemical Prophylaxis of Thromboembolism in Surgical Patients, Clinical and Applied Thrombosis/Hemostasis,2014, Vol. 20(5) 493-497.
4. Amin, A, Stemkowski, S, Lin, J, Yang, G. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007;5(8):1610–1616).
5. Balk EM, Ellis AG, Di M, Adam GP, Trikalinos TA (2017) Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update. Rockville
6. Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898–944.
7. Menaka Pai and James D Douketis, Prevention of venous thromboembolic disease in surgical patiens. www.uptodate.com, 2017.
8. Petersen PB, Kehlet H, Jorgensen CC. Safety of in‐hospital only thromboprophylaxis after fast‐track total hip and knee arthroplasty: a prospective follow‐up study in 17,582 procedures. Thromb Haemost. 2018;118:2152–61.